Work in progress for patient-centricity

Oct 7, 2024 | News

On June 20th, Marta García Manrique, R&D. Chief Patient Officer in Servier and representative in the FACILITATE consortium, presented the main features of the IHI project at the “Patient Centricity & Engagement Conference” in London.

The annual appointment provided the appropriate setting to illustrate the main objectives of FACILITATE and the challenge of finding common solutions to meet the needs of different stakeholders. These are essential to develop a common framework to facilitate and standardize the management of patient data generated during their involvement in clinical trials. 

In her introduction, focused on the need to put the patient at the center of decision making, Marta García highlighted the value of this kind of cross-cutting and multi-stakeholder projects as a helpful tool to advance in the internal transformation of the organizations towards the new patient-centric model. 

FACILITATE meets these requirements perfectly for the goals it seeks to achieve:

  • new legally and ethically ways to allow participants’ data to be accessed and reused
  • a partnership in which patients are at the center of data governance through advanced communication tools and participatory technology
  • a change in our current process of generating evidence from clinical trials, which now is far from straightforward
  • more effective and safer medicines brought faster at their approval date, showing how a patient-centered data driven approach can make the entire process better
  • clear rules in a trusted, ethical, legal, and regulatory ecosystem to strongly engage patients as data generators
  • a change in the current situation of clinical trial data siloed in separate medical systems without possibility to be used beyond their original single-sided purpose.

In her conclusions, Marta García outlined the expected impact of FACILITATE, not only for participants but also for healthcare professionals, who will be able to aid clinical decision making and reduce duplication; for regulators, who could exchange views with counterparts in other countries and with researchers to propose aligned and workable positions; for EU research, which will give patients control over their clinical trial data and allow them to donate it; for pharmaceutical companies, which will be able to improve patient retention and access to health data for future research; and for society, which will increase the transparency of clinical trials and thus improve patient trust and oversight of clinical data reuse.

Recent news

Opportunities and challenges of person-centric research

Opportunities and challenges of person-centric research

The European project FACILITATE has been showcased at the 10th annual Clinical Monitoring & Patient Recruitment Retention Summit on 20-21 November 2024 in Barcelona, with the topic: Advancing Patient Centric Clinical Trials: the case of IHI FACILITATE, returning...

read more
Let’s FACILITATE Webinar 2024

Let’s FACILITATE Webinar 2024

Understanding the Secondary Use of Clinical Trial Data: perspectives from patients, clinicians, industry, and regulators We are delighted to invite you to the II LET’s FACILITATE 2024 Webinar, an engaging exploration and roundtable discussion centered around the...

read more
An ethical-legal framework built on social alliance

An ethical-legal framework built on social alliance

At the 42nd National Congress of the Italian Society of Pharmacology, which was held in Sorrento, Italy, November 13-16, 2024, Veronica Rivi, from the Department of Biomedical, Metabolic and Neuroscience Sciences at UNIMORE and a member of FACILITATE, presented a...

read more

Join our POOL OF STAKEHOLDERS!

Do you want to receive our updates, access information on our activities and events and be in contact with our project?

Latest News

Upcoming Events

Report